Back to results
US 2026/0216292 A1Published application
Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid
AssigneeDompé Farmaceutici S.P.A.
InventorsEnno SCHMIDT, Ralf LUDWIG, Sabrina PATZELT, Andrea ARAMINI, Laura BRANDOLINI, Pasquale COCCHIARO, Gianluca BIANCHINI, Nicola DETTA
Life of this patent
Estimating the term…
Abstract
The invention relates to CXCL8 inhibitors useful in the prevention and/or treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid.
Claims14
A CXCL8 inhibitor for use in the prevention and/or treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid in a subject.
Dependencies are inferred from the claim text.